Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
1. To assess efficacy of nilotinib in pediatric patients with Ph+ CML-CP resistant or intolerant to either imatinib or dasatinib 2. To assess efficacy of nilotinib in pediatric patients with Ph+ CML-AP resistant or intolerant to either imatinib or dasatinib 3. To assess efficacy of nilotinib in pediatric patients with newly diagnosed Ph+ CML-CP
Critère d'inclusion
- - leukemia - leukemia,pediatric - leukemia, myleiod - leukemia, mylegenous, chronic - leukemia, mylegenous, accelerated - BCR-ABL positive - myeloproliferative disorder - bone marrow disease - hematologic diseases - neoplastic processes